Invalid Symbol

Stock Research for PBYI

PBYI
Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

PBYI Stock Chart & Research Data

The PBYI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PBYI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


PBYI Due diligence Resources & Stock Charts

The PBYI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PBYI Detailed Price Forecast - CNN Money CNN View PBYI Detailed Summary - Google Finance
Yahoo View PBYI Detailed Summary - Yahoo! Finance Zacks View PBYI Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View PBYI Trends & Analysis - Trade-Ideas Barrons View PBYI Major Holders - Barrons
NASDAQ View PBYI Call Transcripts - NASDAQ Seeking View PBYI Breaking News & Analysis - Seeking Alpha
Spotlight View PBYI Annual Report - CompanySpotlight.com OTC Report View PBYI OTC Short Report - OTCShortReport.com
TradeKing View PBYI Fundamentals - TradeKing Charts View PBYI SEC Filings - Bar Chart
WSJ View Historical Prices for PBYI - The WSJ Morningstar View Performance/Total Return for PBYI - Morningstar
MarketWatch View the Analyst Estimates for PBYI - MarketWatch CNBC View the Earnings History for PBYI - CNBC
StockMarketWatch View the PBYI Earnings - StockMarketWatch MacroAxis View PBYI Buy or Sell Recommendations - MacroAxis
Bullish View the PBYI Bullish Patterns - American Bulls Short Pains View PBYI Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View PBYI Stock Mentions - StockTwits PennyStocks View PBYI Stock Mentions - PennyStockTweets
Twitter View PBYI Stock Mentions - Twitter Invest Hub View PBYI Investment Forum News - Investor Hub
Yahoo View PBYI Stock Mentions - Yahoo! Message Board Seeking Alpha View PBYI Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for PBYI - SECform4.com Insider Cow View Insider Transactions for PBYI - Insider Cow
CNBC View PBYI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PBYI - OTC Markets
Yahoo View Insider Transactions for PBYI - Yahoo! Finance NASDAQ View Institutional Holdings for PBYI - NASDAQ


Stock Charts

FinViz View PBYI Stock Insight & Charts - FinViz.com StockCharts View PBYI Investment Charts - StockCharts.com
BarChart View PBYI Stock Overview & Charts - BarChart Trading View View PBYI User Generated Charts - Trading View


Latest Financial News for PBYI

New Research Coverage Highlights SunCoke Energy Partners, Carrols Restaurant Group, First Financial, Emerson Electric, Puma Biotechnology, and Amgen — Consolidated Revenues, Company Growth, and Expectations for 2018
Posted on Tuesday February 20, 2018

NEW YORK, Feb. 20, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of SunCoke ...


Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results
Posted on Thursday February 15, 2018

Puma Biotechnology, Inc. , a biopharmaceutical company, will host a conference call at 1:30 p.m. PST/4:30 p.m. EST on Thursday, March 1, 2018 following release of its fourth quarter and full year 2017 financial results.


Today’s Research Reports on Trending Tickers: Nektar Therapeutics and Puma Biotechnology
Posted on Thursday February 15, 2018

NEW YORK, NY / ACCESSWIRE / February 15, 2018 / U.S. markets rallied sharply from early losses Wednesday as inflation fears appear to be easing on Wall Street. The Dow Jones Industrial Average jumped 1.03 ...


Puma Biotechnology to Present at LEERINK Partners Global Healthcare Conference
Posted on Wednesday February 07, 2018

Puma Biotechnology, Inc. , a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 3:30 p.m.


Here's Why Puma Biotechnology Inc. Is Getting Beaten Down Today
Motley Fool - Jan 24, 2018
What happened. Shares of Puma Biotechnology Inc. (NASDAQ:PBYI), a U.S. biotech seeking approval of its breast cancer therapy in the EU, were hit hard after European regulators signaled big trouble for the company's lead drug.
Puma Biotechnology sinks after Europe unlikely to OK breast cancer drug - Reuters
Puma Plunges as Cancer Drug Setback Stuns Wall Street - Bloomberg

Puma Biotechnology: EU Delivers A Blow - And An Opportunity
Seeking Alpha - Jan 25, 2018
Puma Biotechnology (PBYI) took a nasty hit on January 23rd, when the EMA, the EU's equivalent of the FDA, through up a serious roadblock to the approval of the company's drug Nerlynx - also called neratinib - for the treatment of early-stage HER2 ...

Puma Biotechnology to Present at LEERINK Partners Global Healthcare Conference
Business Wire (press release) - Feb 7, 2018
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 3:30 p.m ...
Puma Biotechnology Inc (PBYI) Receives Consensus Rating of “Buy” from Brokerages - Dispatch Tribunal

Puma Biotechnology Inc (PBYI) Plunges 5.05% on February 05
Equities.com - Feb 5, 2018
Puma Biotechnology Inc (PBYI) had a rough trading day for Monday February 05 as shares tumbled 5.05%, or a loss of $-3.25 per share, to close at $61.10.
Redmile Group Lifted Puma Biotechnology (PBYI) Position; As Csx (CSX) Share ... - Thorold News
Puma Biotechnology (PBYI) Getting Somewhat Favorable News Coverage, Report Finds - Week Herald

Enter a stock symbol to view the stock details.